1. Diaphragm Muscle Weakness Following Acute Sustained Hypoxic Stress in the Mouse Is Prevented by Pretreatment with N-Acetyl Cysteine.
- Author
-
O'Leary AJ, Drummond SE, Edge D, and O'Halloran KD
- Subjects
- Acetylcysteine pharmacology, Animals, Atrophy, Autophagy drug effects, Autophagy genetics, Biomechanical Phenomena, Carbon Dioxide metabolism, Chymotrypsin metabolism, Diaphragm drug effects, Diaphragm physiopathology, Forkhead Box Protein O3 metabolism, Gene Expression Regulation drug effects, Hypoxia genetics, Hypoxia physiopathology, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, MAP Kinase Signaling System drug effects, Male, Mice, Inbred C57BL, Muscle Fibers, Skeletal drug effects, Muscle Fibers, Skeletal pathology, Muscle Weakness etiology, Muscle Weakness genetics, Oxidative Stress drug effects, Phosphorylation drug effects, Proteasome Endopeptidase Complex metabolism, Proto-Oncogene Proteins c-akt metabolism, Pulmonary Ventilation drug effects, Respiration, TOR Serine-Threonine Kinases metabolism, Thiobarbituric Acid Reactive Substances metabolism, Acetylcysteine therapeutic use, Diaphragm pathology, Hypoxia complications, Muscle Weakness drug therapy, Muscle Weakness prevention & control, Stress, Physiological drug effects
- Abstract
Oxygen deficit (hypoxia) is a major feature of cardiorespiratory diseases characterized by diaphragm dysfunction, yet the putative role of hypoxic stress as a driver of diaphragm dysfunction is understudied. We explored the cellular and functional consequences of sustained hypoxic stress in a mouse model. Adult male mice were exposed to 8 hours of normoxia, or hypoxia (FiO
2 = 0.10) with or without antioxidant pretreatment (N-acetyl cysteine, 200 mg/kg i.p.). Ventilation and metabolism were measured. Diaphragm muscle contractile function, myofibre size and distribution, gene expression, protein signalling cascades, and oxidative stress (TBARS) were determined. Hypoxia caused pronounced diaphragm muscle weakness, unrelated to increased respiratory muscle work. Hypoxia increased diaphragm HIF-1 α protein content and activated MAPK, mTOR, Akt, and FoxO3a signalling pathways, largely favouring protein synthesis. Hypoxia increased diaphragm lipid peroxidation, indicative of oxidative stress. FoxO3 and MuRF-1 gene expression were increased. Diaphragm 20S proteasome activity and muscle fibre size and distribution were unaffected by acute hypoxia. Pretreatment with N-acetyl cysteine substantially enhanced cell survival signalling, prevented hypoxia-induced diaphragm oxidative stress, and prevented hypoxia-induced diaphragm dysfunction. Hypoxia is a potent driver of diaphragm weakness, causing myofibre dysfunction without attendant atrophy. N-acetyl cysteine protects the hypoxic diaphragm and may have application as a potential adjunctive therapy.- Published
- 2018
- Full Text
- View/download PDF